ERAVEC Trademark

Trademark Overview

On Tuesday, July 7, 2009, a trademark application was filed for ERAVEC with the United States Patent and Trademark Office. The USPTO has given the ERAVEC trademark a serial number of 79073401. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Monday, May 7, 2012. This trademark is owned by CLAVIS PHARMA ASA. The ERAVEC trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of cancer
eravec

General Information

Serial Number79073401
Word MarkERAVEC
Filing DateTuesday, July 7, 2009
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateMonday, May 7, 2012
Registration Number3807302
Registration DateTuesday, June 22, 2010
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 6, 2010

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention and treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateMonday, May 7, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCLAVIS PHARMA ASA
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressNO
Party NameCLAVIS PHARMA ASA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressNO
Party NameCLAVIS PHARMA ASA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressNO

Trademark Events

Event DateEvent Description
Wednesday, February 13, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, May 25, 2012DEATH OF INTERNATIONAL REGISTRATION
Wednesday, October 6, 2010FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, October 6, 2010FINAL DISPOSITION PROCESSED
Thursday, September 23, 2010FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, June 22, 2010REGISTERED-PRINCIPAL REGISTER
Tuesday, April 6, 2010PUBLISHED FOR OPPOSITION
Wednesday, March 17, 2010NOTICE OF PUBLICATION
Wednesday, March 3, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, March 2, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 2, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 2, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 26, 2010ASSIGNED TO LIE
Monday, February 1, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 2, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 1, 2009REFUSAL PROCESSED BY IB
Friday, October 30, 2009NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, October 30, 2009REFUSAL PROCESSED BY MPU
Friday, October 30, 2009NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, October 29, 2009NON-FINAL ACTION WRITTEN
Tuesday, October 27, 2009APPLICATION FILING RECEIPT MAILED
Friday, October 23, 2009ASSIGNED TO EXAMINER
Friday, October 23, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, October 22, 2009SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

eravec cancer treatment prevention preparations pharmaceutical